IRIS
MONTERA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.020
NA - Nord America 2.796
EU - Europa 911
SA - Sud America 276
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 43
OC - Oceania 14
Totale 9.111
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.751
US - Stati Uniti d'America 2.632
CN - Cina 579
IT - Italia 418
HK - Hong Kong 302
BR - Brasile 166
GB - Regno Unito 143
FR - Francia 98
VN - Vietnam 97
BD - Bangladesh 73
CA - Canada 72
DE - Germania 67
IN - India 63
RU - Federazione Russa 39
MX - Messico 33
AR - Argentina 29
NL - Olanda 27
IL - Israele 25
CO - Colombia 24
CZ - Repubblica Ceca 21
EC - Ecuador 18
ID - Indonesia 16
UA - Ucraina 16
TR - Turchia 15
SC - Seychelles 14
AU - Australia 13
IQ - Iraq 13
SV - El Salvador 13
CL - Cile 12
SA - Arabia Saudita 11
ZA - Sudafrica 11
JP - Giappone 10
MY - Malesia 10
CR - Costa Rica 9
ES - Italia 9
CW - ???statistics.table.value.countryCode.CW??? 8
EE - Estonia 8
FI - Finlandia 8
PH - Filippine 8
SE - Svezia 8
VE - Venezuela 8
HN - Honduras 7
PL - Polonia 7
PR - Porto Rico 6
PY - Paraguay 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
GT - Guatemala 5
MD - Moldavia 5
NP - Nepal 5
PK - Pakistan 5
AT - Austria 4
EG - Egitto 4
JM - Giamaica 4
RS - Serbia 4
TW - Taiwan 4
AM - Armenia 3
BE - Belgio 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GP - Guadalupe 3
KE - Kenya 3
KW - Kuwait 3
KZ - Kazakistan 3
LB - Libano 3
LT - Lituania 3
MA - Marocco 3
NI - Nicaragua 3
NO - Norvegia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AO - Angola 2
CH - Svizzera 2
GR - Grecia 2
HU - Ungheria 2
IE - Irlanda 2
KG - Kirghizistan 2
KR - Corea 2
MK - Macedonia 2
NG - Nigeria 2
PT - Portogallo 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
DJ - Gibuti 1
FK - Isole Falkland (Malvinas) 1
GD - Grenada 1
GN - Guinea 1
IR - Iran 1
Totale 9.069
Salva come PNG Salva come JPEG
Città #
Ashburn 706
San Jose 530
Singapore 386
Hong Kong 297
Rome 254
Hefei 177
Beijing 160
Santa Clara 124
Council Bluffs 110
Boardman 95
London 92
Columbus 90
Lauterbourg 75
Shanghai 57
Dallas 44
Los Angeles 39
Ho Chi Minh City 38
Phoenix 37
Munich 32
San Francisco 30
São Paulo 29
Montreal 24
Buffalo 23
New York 23
Brno 21
Hanoi 20
Pune 19
Toronto 17
Washington 17
Milan 16
Mexico City 14
North Bergen 14
Seattle 14
Amsterdam 13
Naples 13
Chicago 12
San Salvador 12
Bogotá 11
Secaucus 11
Brooklyn 10
Grumo Nevano 9
Brasília 8
San José 8
Sorab 8
The Dalles 8
Willemstad 8
Santiago 7
Tokyo 7
Warsaw 7
Canberra 6
Catania 6
Coral Springs 6
Dhaka 6
Frankfurt am Main 6
Kuala Lumpur 6
Las Vegas 6
Paris 6
Quito 6
Rio de Janeiro 6
Atlanta 5
Boston 5
Guayaquil 5
Johannesburg 5
Medellín 5
Montevideo 5
Newark 5
Orem 5
Philadelphia 5
San Pedro Sula 5
Stockholm 5
Asunción 4
Bologna 4
Buford 4
Cleveland 4
Da Nang 4
Denver 4
Guangzhou 4
Guarulhos 4
Guatemala City 4
New Delhi 4
Poplar 4
Ribeirão Preto 4
Riyadh 4
Salt Lake City 4
Tampa 4
Temecula 4
Turku 4
Arecibo 3
Baghdad 3
Baku 3
Cairo 3
Caracas 3
Charlotte 3
Chattanooga 3
Chennai 3
City of London 3
Cusano Milanino 3
Dammam 3
Des Moines 3
Dubai 3
Totale 3.998
Salva come PNG Salva come JPEG
Nome #
Efficacy of termoablative fractional CO2 laser (Monnalisa Touch) in stress urinary incontinence 284
Feasibility and efficacy of Letrozole in heavily pre-treated patients with relapsed ovarian cancer not eligible for further chemotherapy cycles 273
Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life 264
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery 255
Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors 244
Does HE4 have a role as biomarker in the recurrence of ovarian cancer? 241
Anterior colporrhaphy plus inside-out tension-free vaginal tape for associated stress urinary incontinence and cystocele: 10-year follow up results 232
Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma 231
Antiangiogenics and immunotherapies in cervical cancer: an update and future's view 228
Does HE4 have a role in the recurrence of ovarian cancer? 215
Chemotherapy as adjuvant treatment for intermediate-high risk early-stage endometrial cancer a pilot study 215
Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? 214
A critical review on HE4 performance in endometrial cancer: where are we now? 163
Early Mini-Invasive Treatment of Persistent Cervical Dysplasia: Clinical Outcome and Psycho-Relational Impact 160
Role of Protopine and Nuciferine in the Management of Nocturia, Urgency, and Dysuria in Pre- and Postmenopausal Women: A Prospective Pilot Study 159
An ultra-miniinvasive treatment for stress urinary incontinence in complicated older patients 144
A new type of absorbable barbed suture for use in laparoscopic myomectomy 144
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 140
Adjuvant chemotherapy after primary treatments for cervical cancer: a critical point of view and review of the literature 140
Does Extensive Upper Abdomen Surgery During Primary Cytoreduction Impact on Long-term Quality of Life? 138
Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy 137
Aortic lymphadenectomy in cervical cancer: Anatomy, classification and technique 135
Bladder function after laparoscopic nerve-sparing radical hysterectomy 135
A gastrointestinal stromal tumor presenting as a pelvic mass: A case report 133
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels 129
The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case-control study 129
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey 126
Long-term follow-up of bulking agents for stress urinary incontinence in older patients 120
The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial 114
Pelvic-cutaneous fistula after retropubic vaginal tape placement 111
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 104
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer 101
Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? 96
Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway 95
Ureteral injuries management in gynaecologic surgery: the role of the conservative approach 95
Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4 93
Ovarian cancer relapse: From the latest scientific evidence to the best practice 89
Influence of pneumoperitoneum pressure on surgical field during robotic and laparoscopic surgery: a comparative study 85
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques 82
Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery 77
The True Impact of Voiding Dysfunctions after Transobturator Sub-Urethral Tape Procedures: A Systematic Review of Literature 76
The role of peritoneal lavage in benign gynecologic laparoscopic surgery 75
Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy 74
REM (Risk of Endometrial Malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy 71
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients 70
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review 69
Ten years of HPV vaccines: State of art and controversies 69
Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study 69
Tension-free vaginal tape versus transobturator suburethral tape: Five-year follow-up results of a prospective, randomised trial 68
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature 68
Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study 68
Surgical primary treatment of stage IVA cervical cancer: A multicentre retrospective study 68
Update on lymphadenectomy in early and advanced ovarian cancer 66
Sacral neuromodulation after stabilization of L2-S1 vertebrae with metallic fixation devices: is it feasible? 66
PROGNOSTIC FACTORS AND BYOCHEMISTRY IN PATIENTS WITH OVARIAN CANCER: A NEW CLINICAL MODEL OF PREDICTION 66
Real-time infrared thermography for ureter detection during hysterectomy 66
Effectiveness of CO2 laser on urogenital syndrome in women with a previous gynecological neoplasia: a multicentric study 64
The effects of giving patients verbal or written pre-operative information in gynecologic oncology surgery: a randomized study and the medical-legal point of view 64
Continuous wound infusion as a valid alternative to tap block for postoperative analgesia after abdominal hysterectomy: A randomized controlled trial 63
Tailoring parametrectomy for early cervical cancer (Stage IA-IIA FIGO): a review on surgical, oncologic outcome and sexual function 63
METODO PER LA DETERMINAZIONE DI UN INDICE PREDITTIVO DEL RISCHIO DI TUMORE DELL’ENDOMETRIO 63
Hormone replacement therapy in cancer survivors: Utopia? 60
Surgical treatment of rectovaginal endometriosis with extensive vaginal infiltration: results of a systematic three-step vagino-laparoscopic approach 60
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset 59
The use of novel hemostatic sealant (Tisseel (R)) in laparoscopic myomectomy: a case-control study 58
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial 58
The role of novel biomarker HE4 in endometrial cancer: a case control prospective study 58
Update on urodynamic bladder dysfunctions after radical hysterectomy for cervical cancer 56
Tailored Treatment Strategies in First Line Therapy for Ovarian Cancer Patients: A Critical Review of the Literature 55
Learning curves of a resident surgeon performing transobturator tape procedures for stress urinary incontinence 54
The role of macroplastique implantation in the management of occult urinary stress incontinence 54
Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy 54
Use of liposome encapsulated doxorubicin citrate (LEDC) as a valid drug in patients affected by ovarian cancer suffering from chemotherapy side-effects 53
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 51
Post-radical hysterectomy detrusor dysfunctions: is sacral neurostimulation a valid treatment strategy? 51
Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer 51
The role of human epididymis protein 4 as a biomarker in gynecologic malignancies 51
Suburethral sling in autoimmune patients: complications, quality of life, and success rate 51
Vaginectomy as treatment of isolated vaginal relapse (IVR) of gynecological neoplasms 50
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 49
Success rates, quality of life, and feasibility of sacral nerve stimulation in elderly patients: 1-year follow-up 47
Use of carboplatinum as neoadjuvant setting for patients affected by locally advanced cervical cancer 46
Use of Sensor Array Analysis to Detect Ovarian Cancer through Breath, Urine, and Blood: A Case-Control Study 44
The novel biomarker HE4 versus CA125 in detecting endometrial cancer: A case control prospective study 44
Surgical primary treatment of stage IVA cervical cancer: A multicenter retrospective study. 42
QUALITY OF LIFE IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: CHEMOTHERAPY VERSUS SURGERY PLUS CHEMOTHERAPY 42
Reply from Authors re: Elisabetta Costantini, Massimo Lazzeri. Elephants Can Remember. Eur Urol 2010;58: 678-9 40
IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers 39
Use of carboplatinum as neoadjuvant setting for patients affected by locally advanced cervical cancer 38
Totale 9.111
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.090
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022122 0 0 0 0 0 0 0 4 1 4 0 113
2022/202345 0 1 1 0 1 1 10 2 2 3 16 8
2023/2024443 14 39 28 36 36 137 5 60 8 13 34 33
2024/20254.104 78 22 118 27 25 90 62 37 228 265 1.429 1.723
2025/20263.123 266 142 125 268 161 190 880 198 295 333 136 129
2026/20271.265 59 316 345 360 185 0 0 0 0 0 0 0
Totale 9.111